Watchlist Price Alert

Entrada Therapeutics Inc. (TRDA)

NASDAQ: TRDA · Real-Time Price · USD

7.95

-0.29 (-3.52%)

At close: Jun 04, 2025, 3:59 PM

7.93

-0.25%

After-hours: Jun 04, 2025, 04:04 PM EDT

-3.52% (1D)

Bid	7.8
Market Cap	301.73M
Revenue (ttm)	172.22M
Net Income (ttm)	24.78M
EPS (ttm)	0.58
PE Ratio (ttm)	13.71
Forward PE	-1.9
Analyst	Buy

Ask	8.75
Volume	81,456
Avg. Volume (20D)	139,903
Open	8.44
Previous Close	8.24
Day's Range	7.93 - 8.44
52-Week Range	7.10 - 21.79
Beta	0.03

About TRDA

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol TRDA

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for TRDA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

9 months ago

+11.26%

Entrada Therapeutics shares are trading higher. Th... Unlock content with Pro Subscription

News

3 weeks ago · zacks.com

Entrada Therapeutics, Inc. (TRDA) Reports Q1 Loss, Tops Revenue Estimates

Entrada Therapeutics, Inc. (TRDA) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.78. This compares to earnings of $0.68 per share a year ago.

1 month ago · zacks.com

Analysts Estimate Entrada Therapeutics, Inc. (TRDA) to Report a Decline in Earnings: What to Look Out for

Entrada Therapeutics (TRDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.